Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
King Of Prussia, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Phio Pharmaceuticals Corp. has filed 870 SEC EDGAR filings since 25 Oct 2011

SEC filing history

Showing 51-75 of 870 matching filings.

Per page
25
Current page
3
S-8 File 333-290186

REGISTRATION STATEMENT

Filing date
11 Sep 2025
Reporting date
Not listed
Next action
Verify source filing
8-K File 001-36304

CURRENT REPORT

Filing date
03 Sep 2025
Reporting date
03 Sep 2025
Next action
Verify source filing
DEFA14A File 001-36304

ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS

Filing date
28 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-289621

PROSPECTUS

Filing date
27 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-289621

EFFECT filing

Filing date
22 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
21 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-289621

UPLOAD filing

Filing date
21 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-289621

REGISTRATION STATEMENT

Filing date
15 Aug 2025
Reporting date
Not listed
Next action
Verify source filing
10-Q File 001-36304

FORM 10-Q FOR JUN 2025

Filing date
14 Aug 2025
Reporting date
30 Jun 2025
Next action
Verify source filing
8-K File 001-36304

CURRENT REPORT

Filing date
14 Aug 2025
Reporting date
14 Aug 2025
Next action
Verify source filing
SCHEDULE 13G/A File 005-86901

SCHEDULE 13G/A filing

Filing date
07 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-553575

D filing

Filing date
04 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-36304

FORM ARS

Filing date
30 Jul 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36304

ADDITIONAL DEFINITIVE PROXY MATERIALS

Filing date
30 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36304

DEFINITIVE PROXY

Filing date
30 Jul 2025
Reporting date
11 Sep 2025
Next action
Verify source filing
8-K File 001-36304

CURRENT REPORT

Filing date
25 Jul 2025
Reporting date
25 Jul 2025
Next action
Verify source filing
8-K File 001-36304

CURRENT REPORT

Filing date
07 Jul 2025
Reporting date
07 Jul 2025
Next action
Verify source filing
8-K File 001-36304

CURRENT REPORT

Filing date
26 Jun 2025
Reporting date
25 Jun 2025
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
18 Jun 2025
Reporting date
06 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
11 Jun 2025
Reporting date
10 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
11 Jun 2025
Reporting date
10 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
10 Jun 2025
Reporting date
09 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
23 May 2025
Reporting date
21 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .